The evaluation and management of patients with neuroleptic malignant syndrome.
NMS is a rare but fatal syndrome that needs to be considered in the perioperative period. Although many aspects remain unexplored and controversial, with greater awareness of the condition, new concepts are coming into light. Definitive treatment guidelines remain an important issue to be addressed. Efforts have been initiated in that direction and all cases can be reported on a toll-free hotline ( 1-888-667-8367) or online (www.nmsis.org).
Bhanushali
Minal J
MJ
Department of Neurology, University of Minnesota, Minneapolis, Minnesota 55455, USA.
Tuite
Paul J
PJ
D014150:Antipsychotic Agents / Q000009:adverse effects; D002389:Catatonia / Q000175:diagnosis; D003937:Diagnosis, Differential; D004565:Electroconvulsive Therapy / Q000379:methods; D006801:Humans; D008305:Malignant Hyperthermia / Q000175:diagnosis; D009203:Myocardial Infarction / Q000139:chemically induced; D009459:Neuroleptic Malignant Syndrome / Q000175:diagnosis* / Q000503:physiopathology / Q000628:therapy*; D020230:Serotonin Syndrome / Q000175:diagnosis
D014150:Antipsychotic Agents